Back to top

J.P. Morgan Remains a Buy on Healthequity (HQY)

In a report released today, Alexei Gogolev from J.P. Morgan reiterated a Buy rating on Healthequity, with a price target of $123.00. According to T...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

HealthEquity, Inc. (HQY)